Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001662244-18-000002
Filing Date
2018-05-16
Accepted
2018-05-16 12:17:29
Documents
1
Effectiveness Date
2018-05-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10291
  Complete submission text file 0001662244-18-000002.txt   11315
Mailing Address 763E CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 763E CONCORD AVENUE CAMBRIDGE MA 02138 617-248-5239
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-308831 | Film No.: 18839376